We are laser-focused on getting what our partners need for the next stage. AvantGen provides a great platform and a dedicated, flexible, and communicative team that has resulted in success for multiple projects. Working with AvantGen on multiple antibody discovery projects was an outstanding experience. Interestingly, our popular AvantGeneer affinity maturation platform has been frequently used to optimize client antibodies that were originally discovered with hybridoma and human transgenic mouse platforms. Their innovative approach and collaborative mindset greatly contributed to the success of our program. Boosting the human innate immune system is a promising approach to cancer immunotherapy, and we have developed a Natural Killer (NK) cell engager platform. It’s important that both labeled and unlabeled antigens are QC’ed by provider, third party, and/or AvantGen.
San Diego, United States
Founded in 2006
11-50 Employees
Working industry
Biotechnology
Type of company
-
Ownership structure
Privately Held
Locations
1 Headquarter
Specialised areas
Health Care, Other Professional, Scientific, and Technical Services, Research services, except laboratory, Biotechnology, Health Diagnostics, Professional, Scientific, and Technical Services
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
United States
Overall risk estimation:
Low
The ESG Data of countries are based on public sources
Environment
D
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
AvantGen operates in 1 country around the world
Get an overview of the locations of AvantGen
Location
Country
State
City
Headquarter
United States
California
San Diego
Some frequent questions that have been asked about AvantGen
Where is AvantGen located?
The company headquarter of AvantGen is located in San Diego, California, United States. It's worth noting, that the company may have more locations
How many employees does AvantGen approximately have?
As of the latest available information AvantGen has around 11-50 employees worldwide.
When was AvantGen founded?
AvantGen was founded in 2006
In which industries does AvantGen mainly work?
The company AvantGen has it's main focus in the industries of Biotechnology
Check out some interesting alternative companies to AvantGen
Adagene
Suzhou City, China
11-50 Employees
2011
Adagene has created a platform composed of unique, multi-purpose, antibody technologies and a growing pipeline of leading assets with novel MOAs. Empowered by precision engineering, Adagene identifies and selects antibody candidates that are most likely to achieve the desired biological effects. Our core technology is built upon our fundamental understanding of the role that protein folding and the motion of molecules play in giving rise to dynamic conformational diversity, where an amino acid sequence can adopt multiple structures and functions.
Hybrigenics Services
Évry-Courcouronnes, France
11-50 Employees
1998
With our innovative technologies and team of experts, we are supporting the scientific community to Achieve their goals, Advance their knowledge about protein interactions and make new Discoveries.We ought to be the best Y2H based and nanobody partner to make breaktroughs possible. Working with Hybrigenics staff is more like having a collaborator than a service provider…staff is very knowledgeable and highly responsive..their expertise and novel methodology gives high hit.. They undertook our project as a research collaboration with a goal to deliver us reliable/high quality data. Staff were in constant communication and consultation with us the entire way, and ultimately provided a set of novel high-confidence MYC interactors that we still work on to this day. Working with Hybrigenics staff is more like having a collaborator than a service provider…staff is very knowledgeable and highly responsive..their expertise and novel methodology gives high hit reliability.
Green Mountain Antibodies
Burlington, United States
11-50 Employees
1996
We are an extension of your lab and are part of your team working together towards a common goal. Custom projects managed from antigen design through production, purification and characterization. Combining our deep knowledge base with years of hands-on experience, we can deliver what you need, when you need it and on budget. GMAb provides excellent services related to monoclonal antibody technology, including the development of novel antibodies, immunoassay design and methods for antibody characterization.
GigaGen
South San Francisco, United States
11-50 Employees
2010
GigaGen’s novel technology platforms uniquely capture and recreate complete immune repertoires as functional antibody libraries. GigaGen’s lead oncology asset, GIGA-564, is an anti-CTLA-4 monoclonal antibody that has demonstrated improved anti-tumor efficacy in vivo through a unique mechanism of action. GigaGen is leveraging its proprietary technology platforms for the continued discovery of novel recombinant polyclonal drugs and monoclonal antibodies to treat life-threatening diseases. GigaGen Publishes Research Showcasing First-Ever Clinical GMP Manufacturing and IND-Enabling Studies for its New Class of Drugs, Recombinant Polyclonal Antibodies. GigaGen Publishes Research Demonstrating the Potential of its Machine Learning Platform to Improve Antibody Drug Discovery and Development. GigaGen Licenses ProteoNic’s 2G UNic Technology Platform for High Yield Production of GigaGen’s Mono- and Polyclonal Antibody Drug Candidates. Biocentury: GigaGen aims to overcome supply limits, boost potency with recombinant convalescent sera substitute. GigaGen’s platform technologies significantly increase the productivity and speed of target and drug discovery, quickly filling a growing pipeline of transformative antibody drugs.
new/era/mabs GmbH
Potsdam, Germany
1-10 Employees
2014
We provide high-end antibody discovery workflows four times faster than conventional state-of-the-art processes. We are very convinced of the quality of their work and the reliability and passion to solve any custom-related issues. We offer the customized generation and production of mouse, camelid, and human antibodies for various in vitro and in vivo applications. Founded in 2014 as an university spin-off located at the Potsdam Science Park the company is embedded in a vibrant scientific environment. To increase the efficacy of this process we developed a hyper-immunization protocol based on viral carrier proteins. In combination with selma as selection tool we provide a high end solution for the discovery of antibody producing hybridoma cells four times faster than with conventional methods. This is a very interesting feature for in vitro diagnostic applications. Creating innovative antibodies with new/era/mabs was a snap.
Fusion Antibodies
Belfast, United Kingdom
11-50 Employees
2001
We are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics to clinical Cell Line Development. Established in 2001, Fusion Antibodies is a Collaborative Research Organisation (CRO) with its headquarters in Northern Ireland. Fusion offers flexibility and agility while delivering clinical candidates focusing on developability, manufacturability and function. We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. We offer a complete end-to-end service from antigen design to cell line development. We work in partnership as an extension of your team to deliver the project requirements while also considering long term goals of manufacturability and commercialization. According to this CMO, the antibody is the poster child for the best producing and most well-behaved antibody they have seen to date, and it will serve as the benchmark to match or exceed for their future projects.